Sheena Iyengar's Jam Study Fails Outside the Lab

The omnipotence dilemma—the idea that unlimited options paralyze us into inaction—has become the comforting diagnosis for our age of infinite scrolling and unfinished projects.

Too many choices, the argument goes, so we choose nothing. We sit in front of the laptop and the weight of possibility flattens us.

This idea came from Sheena Iyengar and Barry Schwartz's work in the 2000s, particularly Schwartz's famous jam experiment—people shown 24 jam varieties bought less than those shown six. The finding was intuitive, depressing. Replicable in controlled conditions where the only variable is the number of options on a shelf and the only cost is jam you might not want.

But this effect has barely survived contact with real life. When researchers tested the same logic in high-stakes scenarios—job selection, medical treatment, investment decisions—the paralysis disappeared. People don't freeze when the choice matters. They get sharp.

The unstated assumption is that decision-making is fundamentally the same whether you're choosing between jams or choosing what work to do with your finite creative life. It isn't. In the high-stakes domain, constraint and choice operate together—deadlines work, stakeholders work, actual consequences work. A filmmaker with three scripts to choose from doesn't sit paralyzed by omnipotence. She knows which one she can actually get made. One her collaborators believe in, which one the market will fund.

That distinction changes whether the diagnosis applies to you at all. If your paralysis comes from genuinely incomparable alternatives in a frictionless vacuum, you might need constraints imposed. If it comes from options that feel weighty but are functionally interchangeable, you might need better information or higher stakes, not fewer choices. What matters is not whether unlimited options are paralyzing in general, it's what you're actually choosing between and why that choice matters.